[IMRX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[IMRX] Immuneering Corporation
Announcement Date
10-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -26.37%
YoY- -84.78%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 38 94 184 190 482 660 748 -86.25%
PBT -12,844 -11,527 -12,897 -11,092 -8,534 -7,987 -6,230 61.91%
Tax -344 -52 -29 -307 -17 1 0 -
NP -12,501 -11,527 -12,867 -10,784 -8,534 -7,988 -6,230 59.02%
Tax Rate - - - - - - - -
Total Cost 12,539 11,622 13,051 10,974 9,016 8,648 6,978 47.75%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -32,570.38 -12,208.67 -7,004.48 -5,688.22 -1,770.08 -1,210.18 -832.62 1049.78%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.47 -0.44 -0.49 -0.42 -0.47 -0.33 -0.46 1.44%
EPS Diluted -0.47 -0.44 -0.49 -0.42 -0.47 -0.33 -0.46 1.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.